Marek Pruszyński

1.8k total citations
40 papers, 1.4k citations indexed

About

Marek Pruszyński is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marek Pruszyński has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Radiology, Nuclear Medicine and Imaging, 17 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marek Pruszyński's work include Radiopharmaceutical Chemistry and Applications (29 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Medical Imaging Techniques and Applications (10 papers). Marek Pruszyński is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (29 papers), Monoclonal and Polyclonal Antibodies Research (12 papers) and Medical Imaging Techniques and Applications (10 papers). Marek Pruszyński collaborates with scholars based in Poland, Germany and United States. Marek Pruszyński's co-authors include Michael R. Zalutsky, Aleksander Bilewicz, Tony Lahoutte, Frank Bruchertseifer, Agnieszka Majkowska‐Pilip, Natalia S. Loktionova, Ganesan Vaidyanathan, Nick Devoogdt, Eftychia Koumarianou and Matthias D’Huyvetter and has published in prestigious journals such as Clinical Cancer Research, Nanoscale and Molecules.

In The Last Decade

Marek Pruszyński

36 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Pruszyński Poland 20 1.1k 348 320 250 151 40 1.4k
Kavitha Sunassee United Kingdom 18 574 0.5× 232 0.7× 215 0.7× 205 0.8× 140 0.9× 37 1.2k
Darpan N. Pandya United States 20 741 0.7× 343 1.0× 266 0.8× 144 0.6× 59 0.4× 42 1.0k
Laura A. Bass United States 13 1.1k 1.0× 430 1.2× 344 1.1× 231 0.9× 69 0.5× 15 1.5k
Alexandra D. Varvarigou Greece 19 733 0.7× 371 1.1× 216 0.7× 214 0.9× 89 0.6× 70 1.1k
Nicolas Lepareur France 18 435 0.4× 193 0.6× 154 0.5× 136 0.5× 146 1.0× 52 952
Licia Uccelli Italy 26 1.3k 1.3× 433 1.2× 621 1.9× 176 0.7× 48 0.3× 111 1.9k
Jean‐François Gestin France 21 905 0.9× 336 1.0× 248 0.8× 215 0.9× 55 0.4× 64 1.3k
Agnieszka Majkowska‐Pilip Poland 19 492 0.5× 127 0.4× 257 0.8× 195 0.8× 277 1.8× 44 984
Frederik Cleeren Belgium 20 721 0.7× 474 1.4× 147 0.5× 204 0.8× 66 0.4× 47 1.2k
Gwang Il An South Korea 18 451 0.4× 184 0.5× 116 0.4× 156 0.6× 86 0.6× 41 765

Countries citing papers authored by Marek Pruszyński

Since Specialization
Citations

This map shows the geographic impact of Marek Pruszyński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Pruszyński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Pruszyński more than expected).

Fields of papers citing papers by Marek Pruszyński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Pruszyński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Pruszyński. The network helps show where Marek Pruszyński may publish in the future.

Co-authorship network of co-authors of Marek Pruszyński

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Pruszyński. A scholar is included among the top collaborators of Marek Pruszyński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Pruszyński. Marek Pruszyński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vlk, Martin, Ján Kozempel, Zbyněk Nový, et al.. (2025). In vitro and in vivo evaluation of anti-HER2 antibody conjugates labelled with 225Ac. EJNMMI Radiopharmacy and Chemistry. 10(1). 16–16.
2.
Lobaz, Volodymyr, Rafał Konefał, Ognen Pop‐Georgievski, et al.. (2025). May the target be with you: polysaccharide-coated upconverting nanoparticles for macrophage targeting. Nanoscale. 17(43). 25120–25135. 1 indexed citations
3.
Dekempeneer, Yana, Maria Wojewódzka, Vicky Caveliers, et al.. (2022). Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer. Molecular Cancer Therapeutics. 21(12). 1835–1845. 20 indexed citations
4.
Kalinowska, Monika, Ewelina Gołębiewska, Grzegorz Świderski, et al.. (2022). Fe(III) and Cu(II) Complexes of Chlorogenic Acid: Spectroscopic, Thermal, Anti-/Pro-Oxidant, and Cytotoxic Studies. Materials. 15(19). 6832–6832. 12 indexed citations
5.
6.
Łyczko, Krzysztof, et al.. (2020). Lead(II) complexes with amide-appended tetraazamacrocyclic ligands – Synthesis, structure, characterization and calculation studies. Polyhedron. 192. 114822–114822. 8 indexed citations
7.
Pruszyński, Marek, Agnieszka Majkowska‐Pilip, Sylwia Męczyńska‐Wielgosz, et al.. (2018). Functionalized TiO2 nanoparticles labelled with 225Ac for targeted alpha radionuclide therapy. Journal of Nanoparticle Research. 20(3). 83–83. 45 indexed citations
8.
D’Huyvetter, Matthias, Jens De Vos, Catarina Xavier, et al.. (2017). 131I-labeled Anti-HER2 Camelid sdAb as a Theranostic Tool in Cancer Treatment. Clinical Cancer Research. 23(21). 6616–6628. 141 indexed citations
9.
Pruszyński, Marek, Agnieszka Majkowska‐Pilip, Krzysztof Łyczko, et al.. (2017). 211 At labeled substance P (5–11) as potential radiopharmaceutical for glioma treatment. Nuclear Medicine and Biology. 53. 1–8. 22 indexed citations
10.
Choi, Jae‐Yeon, Ganesan Vaidyanathan, Eftychia Koumarianou, et al.. (2014). N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: Influence of isomeric substitution on radiolabeling and target cell residualization. Nuclear Medicine and Biology. 41(10). 802–812. 17 indexed citations
11.
Pruszyński, Marek, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.. (2014). Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling. Journal of Nuclear Medicine. 55(4). 650–656. 79 indexed citations
12.
Pruszyński, Marek, Eftychia Koumarianou, Ganesan Vaidyanathan, Satish K. Chitneni, & Michael R. Zalutsky. (2014). D-amino acid peptide residualizing agents bearing N-hydroxysuccinimido- and maleimido-functional groups and their application for trastuzumab radioiodination. Nuclear Medicine and Biology. 42(1). 19–27. 8 indexed citations
13.
Pruszyński, Marek, et al.. (2014). Adsorption of 137Cs on titanate nanostructures. Journal of Radioanalytical and Nuclear Chemistry. 301(3). 889–895. 36 indexed citations
14.
Koumarianou, Eftychia, Tatiana A. Slastnikova, Marek Pruszyński, et al.. (2014). Radiolabeling and in vitro evaluation of 67Ga-NOTA-modular nanotransporter – A potential Auger electron emitting EGFR-targeted radiotherapeutic. Nuclear Medicine and Biology. 41(6). 441–449. 34 indexed citations
15.
Pruszyński, Marek, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.. (2012). Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody. Nuclear Medicine and Biology. 40(1). 52–59. 91 indexed citations
16.
Pruszyński, Marek, Agnieszka Majkowska‐Pilip, Natalia S. Loktionova, Elisabeth Eppard, & Frank Roesch. (2012). Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc. Applied Radiation and Isotopes. 70(6). 974–979. 75 indexed citations
17.
Zalutsky, Michael R. & Marek Pruszyński. (2011). Astatine-211: Production and Availability. Current Radiopharmaceuticals. 4(3). 177–185. 144 indexed citations
18.
Pruszyński, Marek, et al.. (2010). Radiolabeling of DOTATOC with 44T/44Sc generator-derived 44Sc. 51(6). 1534–1534. 1 indexed citations
19.
Lebeda, O. & Marek Pruszyński. (2010). New measurement of excitation functions for (p,x) reactions on natMo with special regard to the formation of 95mTc, 96m+gTc, 99mTc and 99Mo. Applied Radiation and Isotopes. 68(12). 2355–2365. 65 indexed citations
20.
Pruszyński, Marek & Aleksander Bilewicz. (2004). Astat w chemii i medycynie. 403425–403425.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kavitha Sunassee Breakdown of academic impact, for papers by Darpan N. Pandya Breakdown of academic impact, for papers by Laura A. Bass Breakdown of academic impact, for papers by Alexandra D. Varvarigou Breakdown of academic impact, for papers by Nicolas Lepareur Breakdown of academic impact, for papers by Licia Uccelli Breakdown of academic impact, for papers by Jean‐François Gestin Breakdown of academic impact, for papers by Agnieszka Majkowska‐Pilip Breakdown of academic impact, for papers by Frederik Cleeren Breakdown of academic impact, for papers by Gwang Il An
Rankless by CCL
2026